Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 24;6(11):e012457.
doi: 10.1136/bmjopen-2016-012457.

Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study

Affiliations

Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study

Ran Sturlaugsdottir et al. BMJ Open. .

Abstract

Objective: Carotid plaque and intima-media thickness are non-invasive arterial markers that are used as surrogate end points for cardiovascular disease. The aim was to assess the prevalence and severity of carotid plaque, and examine its determinant risk factors and their association to the common carotid artery intima-media thickness (CCA-IMT) in a general population.

Methods: We examined 6524 participants aged 25-69 years in the population-based REFINE (Risk Evaluation For INfarct Estimates)-Reykjavik study. Plaques at the bifurcation and internal carotid arteries were evaluated. Mean CCA-IMT was measured in the near and far walls of the common carotid arteries.

Results: The prevalence of minimal, moderate and severe plaque was 35.0%, 8.9% and 1.1%, respectively, and the mean CCA-IMT was 0.73 (SD 0.14) mm. Age, sex, smoking and type 2 diabetes mellitus (T2DM) were the strongest risk factors associated with plaque, followed by systolic blood pressure, total cholesterol, body mass index and family history of myocardial infarct. Low educational level was also strongly and independently associated with plaque. CCA-IMT shared the same risk factors except for a non-significant association with T2DM and family history of myocardial infarction (MI). Participants with T2DM had greater plaque prevalence, 2-fold higher in those <50 years and 17-30% greater in age groups 50-54 to 60-64, and more significant plaques (moderate or severe) were the difference in prevalence was 24% in age group 50-54 and ≥60% in older age groups, compared with non-T2DM.

Conclusions: Carotid plaque and CCA-IMT have mostly common determinants. However, T2DM and family history of MI were associated with plaque but not with CCA-IMT. Greater prevalence and more severe plaques in individuals with T2DM raise the concern that with increasing prevalence of T2DM we may expect an increase in atherosclerosis and its consequences.

Keywords: atherosclerosis; carotid arteries; risk factors; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Carotid plaque prevalence and severity (A), and mean CCA-IMT, 10th (P10) and 90th (P90) centiles (B) by age group. CCA-IMT, common carotid artery intima-media thickness.
Figure 2
Figure 2
Carotid plaque prevalence and severity (A), and mean CCA-IMT (B) in participants with no T2DM and those with T2DM by age group. CCA-IMT, common carotid artery intima-media thickness; Min, minimal plaque; Sign, significant plaque (diagonal pattern fill); T2DM, type 2 diabetes mellitus.

References

    1. Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta 1996;246:21–38. 10.1016/0009-8981(96)06224-9 - DOI - PubMed
    1. Aspelund T, Gudnason V, Magnusdottir BT et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25–74 between the years 1981 and 2006. PLoS ONE 2010;5:e13957 10.1371/journal.pone.0013957 - DOI - PMC - PubMed
    1. Ford I, Murray H, Packard CJ et al. Long-term follow-up of the West of Scotland coronary prevention study. N Engl J Med 2007;357:1477–86. 10.1056/NEJMoa065994 - DOI - PubMed
    1. Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke 2010;41:1193–9. 10.1161/STROKEAHA.110.577973 - DOI - PubMed
    1. Spence JD, Eliasziw M, DiCicco M et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002;33:2916–22. 10.1161/01.STR.0000042207.16156.B9 - DOI - PubMed

Publication types